Cipla | CIPLA - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Arca Biopharma USD -36.43M 2M 2026-03
aTyr Pharma USD -104K 24K 2026-06
Bio Path USD -297K 191K 2026-03
Brainstorm Cell Therapeutics USD -2.05M 198K 2026-03
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cipla INR 10.43B 1.55B 2026-09
Dr.Reddys Laboratories INR 12.16B 8.91B 2026-09
Immunic USD -23.33M 2.67M 2025-12
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sun Pharmaceuticals INR 39.07B 3.5B 2026-09
TherapeuticsMD USD -1.18M 40K 2024-06
UPL INR 14.93B 8.25B 2026-09